AL Sydbank (ALSYDB) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
13 Jun, 2025Executive summary
Profit for H1 2024 reached DKK 1,624m, up 9% year-over-year, with a return on equity of 22.4% after tax.
Core income rose 8% to DKK 3,646m, driven by higher interest rates and increased lending and deposits.
Bank loans and advances increased by DKK 4.7bn (6%) since year-end 2023, mainly from corporate clients.
Acquisition of Coop Bank A/S completed on 1 July 2024 for DKK 345m, expected to boost business volume.
Financial highlights
Total income for H1 2024 was DKK 3,799m, up 6% year-over-year.
Trading income declined to DKK 153m from DKK 186m in H1 2023.
Costs (core earnings) increased 4% to DKK 1,659m, in line with expectations.
Core earnings before impairment rose 8% to DKK 2,140m.
Impairment charges for loans and advances were DKK 24m, compared to an income of DKK 16m in H1 2023.
Outlook and guidance
Profit after tax for 2024 is expected in the range of DKK 2,800-3,100m, revised up from previous guidance.
Forecast assumes a 0.50pp interest rate cut by Danmarks Nationalbank in 2024.
Outlook remains subject to macroeconomic and financial market uncertainties, especially regarding impairment charges.
Latest events from AL Sydbank
- Profit and core income surged post-merger, with robust capital ratios and a cautious outlook.ALSYDB
Q1 20266 May 2026 - 2025 profit reached DKK 1,893m, with merger driving scale and capital ratios down.ALSYDB
Q4 202525 Feb 2026 - Profit after tax was DKK 1,922m with 17.4% ROE and a transformative merger underway.ALSYDB
Q3 20255 Nov 2025 - H1 2025 profit was DKK 1,212m, with 16.7% ROE and a strong capital position.ALSYDB
Q2 202527 Aug 2025 - Profit after tax was DKK 2,396m, with 4% core income growth and upgraded 2024 guidance.ALSYDB
Q3 202413 Jun 2025 - Profit declined on lower income and higher costs, but capital strength and liquidity remain robust.ALSYDB
Q1 20255 Jun 2025 - 2024 profit fell to DKK 2,762m as costs rose and impairments surged, with cautious 2025 outlook.ALSYDB
Q4 20245 Jun 2025